Harbin Fuerjia Technology Future Growth
Future criteria checks 1/6
Harbin Fuerjia Technology is forecast to grow earnings and revenue by 8.4% and 11% per annum respectively. EPS is expected to grow by 6.6% per annum. Return on equity is forecast to be 12.7% in 3 years.
Key information
8.4%
Earnings growth rate
6.6%
EPS growth rate
Medical Equipment earnings growth | 26.3% |
Revenue growth rate | 11.0% |
Future return on equity | 12.7% |
Analyst coverage | Good |
Last updated | 05 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 2,634 | 874 | N/A | 854 | 6 |
12/31/2025 | 2,374 | 803 | N/A | 749 | 7 |
12/31/2024 | 2,132 | 736 | N/A | 836 | 7 |
9/30/2024 | 2,060 | 727 | 577 | 709 | N/A |
6/30/2024 | 2,005 | 736 | 669 | 754 | N/A |
3/31/2024 | 1,970 | 742 | 662 | 774 | N/A |
12/31/2023 | 1,934 | 749 | 706 | 826 | N/A |
9/30/2023 | 1,794 | 735 | 481 | 730 | N/A |
6/30/2023 | 1,821 | 843 | 515 | 902 | N/A |
3/31/2023 | 1,788 | 845 | 481 | 912 | N/A |
1/1/2023 | 1,769 | 847 | 500 | 899 | N/A |
3/31/2022 | 1,657 | 794 | 632 | 786 | N/A |
12/31/2021 | 1,650 | 806 | 643 | 802 | N/A |
12/31/2020 | 1,585 | 648 | 668 | 671 | N/A |
12/31/2019 | 1,342 | 661 | 692 | 726 | N/A |
12/31/2018 | 373 | 200 | 214 | 218 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 301371's forecast earnings growth (8.4% per year) is above the savings rate (2.8%).
Earnings vs Market: 301371's earnings (8.4% per year) are forecast to grow slower than the CN market (26.1% per year).
High Growth Earnings: 301371's earnings are forecast to grow, but not significantly.
Revenue vs Market: 301371's revenue (11% per year) is forecast to grow slower than the CN market (13.8% per year).
High Growth Revenue: 301371's revenue (11% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 301371's Return on Equity is forecast to be low in 3 years time (12.7%).